Approximately 50-55% of blood is comprised of plasma; red blood cells, white blood cells and platelets account for most of the remaining volume. Plasma-derived products are manufactured from healthy human plasma.
Plasma-derived products are crucial for the replacement of lost fluids and to maintain adequate blood volume and pressure during emergency medical treatment, as well as in cases of shock due to blood loss, trauma or burns. They are also used to treat edema or ascites caused by liver cirrhosis, nephropathy, and cancer chemotherapy, etc.
Plasma-derived products are used for the prevention and treatment of epidemic diseases such as atypical pneumonia, influenza A virus subtype H3N2 and hand-foot-mouth disease.
Plasma-derived products are important in the treatment of immune system disorders including primary immunodeficiency (PID), secondary immunodeficiency (SID), auto-immune deficiency diseases (AID) and chronic inflammatory demyelinating polyneuropathy (CIDP).
Plasma-derived products are used to produce immune antibodies rapidly in the absence of antibodies for diseases including hepatitis B, rabies and tetanus.
Plasma-derived products are used in the treatment of congenital and acquired bleeding disorders such as hemophilia as well as diseases of the liver.
